The Efficacy and Safety of Oxcarbazepine on Posttraumatic Epilepsy

王学玲,赵永青,张赛

2010-01-01

Abstract:[Objective]To observe the efficacy and safety of Oxcarbazepine (OXC) in treating posttraumatic epilepsy (PTE). [Method]66 cases of posttraumatic epilepsy was continuously treated at Epilepsy Center of our hospital from March 2007 to September 2008. Among which,10 cases had not received any AEDs treatment and 46 cases had treated with non-standard before and received single OXC drug treatment,10 cases had taken Depakine combined with OXC,monotherapy's dose maintained at 600～1 500 mg and combination therapy dose maitained at 600～1 200 mg. Comparison of open self-observation for 12 months,the control rate of OXC to seizures,the improvement of EEG and the adverse reactions and safety were evaluated. [Results]The total effective rate of OXC for posttraumatic epilepsy was 85.94%,the control rate was 56.25%,compared the results of EEG before and after treatment showed that EEG was significantly improved after 12 months of treatment(P 0.01). Common adverse reaction were dizziness,lethargy,inability,headache,nausea,loss of appetite,leukopenia,tremor and rash. Withdrawal due to adverse drug reactions in 2 cases and accounting for 3.03%. The routine blood test,liver and kidney function and ECG had no significant changes before and after treatment(P 0.05). [Conclusions]In 66 of cases posetraumatic epilepsy is treating with oxcarbazepine effective,high security and with mild adverse reaction.